Table I.
Baseline Clinical Characteristics of the Entire Cohort and Both Study Groups
| cohort (N=60) | statin group (n=30) | placebo group (n=30) | P value a | |
|---|---|---|---|---|
| Age, y | 38.3±10.5 | 38.7±11 | 37.9±9.9 | >.05 |
| Men | 30 (50) | 14 (46.7) | 16 (53.3) | >.05 |
| Duration of diabetes mellitus, y | 3.6±8.3 | 3.0±5.4 | 3.9±9.5 | >.05 |
| Hypertension | 48 (80) | 25 (83.3) | 23 (76.7) | >.05 |
| Smoking | 25 (41.7) | 13 (43.3) | 12 (40) | >.05 |
| Dyslipidemiab | 20 (33.3) | 9 (30) | 11 (36.7) | >.05 |
| Total serum cholesterol, mmol/L | 4.8±0.3 | 4.7±0.3 | 4.9±0.2 | >.05 |
Continuous variables are presented as mean ± standard deviation, while categoric variables are presented as numbers (percentage). aComparison between statin group and placebo group. bAbnormal serum triglycerides and/or high‐density lipoprotein cholesterol levels.